Pharmaceutical compounding creates medications that are customized to individual patients, reducing side effects and thereby increasing compliance and ultimately improving outcomes. One of the most powerful ways to customize a medication is through the vehicle that is used to deliver the drug.
Fagron creates innovative dermatological and oral administration vehicles for pharmaceutical compounding. Their research and development pipeline includes unique treatments for psoriasis, atopic dermatitis, alopecia areata, glaucoma, and ocular hypertension.
About Fagron
Fagron, founded in Rotterdam, Netherlands in 1990, is the leading global pharmaceutical compounding company, bringing customized pharmaceutical care to hospitals, pharmacies, clinics, and patients in 35 countries worldwide.
Fagron, Inc. is a leading developer and supplier of innovative delivery vehicles (creams, syrups, and lotions), bulk pharmaceutical ingredients, excipients, and high-quality compounding equipment. Fagron, Inc., is a VAWD accredited, FDA and DEA-registered pharmaceutical manufacturer that strictly adheres to current Good Manufacturing Practices (cGMP).
This post is related to:
USP <795> Non-Sterile Resources, Compliance, Technology
